Indication
For treatment of moderate to severe symptoms of uterine fibroids in adult women of reproductive age.
Medicine details
- Medicine name:
- relugolix/estradiol/norethisterone acetate (Ryeqo)
- SMC ID:
- SMC2442
- Pharmaceutical company
- Gedeon Richter UK Ltd
- BNF chapter
- Obstetrics, gynaecology, and urinary-tract disorders
- Submission type
- Full
- Publication due date:
- 13 June 2022
- Patient group submission deadline:
- 04 April 2022